|
|
|
|
LEADER |
01390nam a2200301 u 4500 |
001 |
EB000942875 |
003 |
EBX01000000000000000736465 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
150223 r ||| eng |
020 |
|
|
|a 9781587633430
|
100 |
1 |
|
|a Segal, Jodi B.
|
245 |
0 |
0 |
|a Hydroxyurea for the treatment of sickle cell disease
|h Elektronische Ressource
|c prepared by the Johns Hopkins University Evidence-based Practice Center ; investigators, Jodi B. Segal ... [et al.]
|
260 |
|
|
|a Rockville, MD
|b Agency for Healthcare Research and Quality
|c 2008, [2008]
|
300 |
|
|
|a ix, 95 p.
|b ill
|
505 |
0 |
|
|a Includes bibliographical references (p. 77-91)
|
653 |
|
|
|a Hydroxyurea / therapeutic use
|
653 |
|
|
|a Anemia, Sickle Cell / drug therapy
|
653 |
|
|
|a Antineoplastic Agents / therapeutic use
|
710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
710 |
2 |
|
|a Johns Hopkins University
|b Evidence-based Practice Center
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Evidence report/technology assessment
|
500 |
|
|
|a "Contract no. 290-02-0018.". - "February 2008."
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK38499
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
856 |
4 |
0 |
|u http://purl.access.gpo.gov/GPO/LPS91282
|3 Volltext
|n Provider site
|3 Volltext
|
082 |
0 |
|
|a 610
|